PlainRecalls
FDA Drug Critical Class I Completed

Vigabatrin for Oral Solution, USP 500 mg per packet, 50 packets per box, Rx Only, Manufactured by: InvaGen Pharmaceuticals, Inc., (a subsidiary of Cipla Ltd.), Hauppauge, NY, 11788, Manufactured for: Cipla USA, Inc., Warren, NJ 07059, NDC 69097-964-53

Reported: January 17, 2024 Initiated: November 17, 2023 #D-0220-2024

Product Description

Vigabatrin for Oral Solution, USP 500 mg per packet, 50 packets per box, Rx Only, Manufactured by: InvaGen Pharmaceuticals, Inc., (a subsidiary of Cipla Ltd.), Hauppauge, NY, 11788, Manufactured for: Cipla USA, Inc., Warren, NJ 07059, NDC 69097-964-53

Reason for Recall

Defective Container: powder may leak out of the pouch

Details

Units Affected
1240 boxes
Distribution
Nationwide within the United States
Location
Central Islip, NY

Frequently Asked Questions

What product was recalled?
Vigabatrin for Oral Solution, USP 500 mg per packet, 50 packets per box, Rx Only, Manufactured by: InvaGen Pharmaceuticals, Inc., (a subsidiary of Cipla Ltd.), Hauppauge, NY, 11788, Manufactured for: Cipla USA, Inc., Warren, NJ 07059, NDC 69097-964-53. Recalled by InvaGen Pharmaceuticals, Inc.. Units affected: 1240 boxes.
Why was this product recalled?
Defective Container: powder may leak out of the pouch
Which agency issued this recall?
This recall was issued by the FDA Drug on January 17, 2024. Severity: Critical. Recall number: D-0220-2024.